LEVOFLOXACIN IN 5% DEXTROSE INJECTION
HIKMA CANADA LIMITED
Quick answers
Is there a shortage of LEVOFLOXACIN IN 5% DEXTROSE INJECTION in Canada?
No. There is no current shortage of LEVOFLOXACIN IN 5% DEXTROSE INJECTION 5MG reported to Health Canada. Stock can still vary from one pharmacy to another.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Closest Matches
LEVAQUIN 5MG/ML
JANSSEN INC
LEVOFLOXACIN IN 5% DEXTROSE INJECTION
STERIMAX INC
Other Products
LEVAQUIN 25MG/ML
JANSSEN INC
LEVAQUIN 500MG
JANSSEN INC
LEVAQUIN
JANSSEN INC
PHL-LEVOFLOXACIN
PHARMEL INC
DIN
02537079
Strength
5MG
Dosage Form
Solution
Route
Intravenous
Compare with another product →
Shortage History
No shortage or discontinuation reports on file for this product.
Other Products from HIKMA CANADA LIMITED
Other Health Canada-approved products made by the same manufacturer — not necessarily related to this shortage, and not necessarily in shortage themselves.
9MG · DIN 02304341
200MG · DIN 02459906
0.4MG · DIN 02432188
0.6MG · DIN 02432196
100MG · DIN 02507668
2MG · DIN 02457075
0.05MG · DIN 02457059
0.2% · DIN 02515377
1G · DIN 02437112
500MG · DIN 02437104
10G · DIN 02437120
2G · DIN 02499096